Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHAGASAZOL: Posaconazole vs Benznidazole in Chronic Chagas Disease
NCT01162967Phase 2Completed
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Sep 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of posaconazole in Chagas disease, sponsored by Vall d'Hebron Research Institute. Started Sep 2010; status: completed.
02
Drugs
posaconazole
03
Conditions
Chagas disease
Beyond the preview
Go deeper on NCT01162967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01162967.